Seeking Alpha

More on Baxter's (BAX) Q4 results: Forecasts current-quarter EPS of $1.03-$1.05 on 2%-3%...

More on Baxter's (BAXQ4 results: Forecasts current-quarter EPS of $1.03-$1.05 on 2%-3% sales growth vs. consensus of $1.10 on 4% revenue growth to $3.5B. Forecasts 2013 EPS of $4.60-$4.70 on 10% sales growth vs. consensus $4.84 on 5% revenue growth of $14.8B. Acquires investigational hemophilia compound OBI-1 and related assets from Inspiration BioPharmaceuticals.

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs